258 related articles for article (PubMed ID: 29891903)
1. Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines.
Porciani D; Cardwell LN; Tawiah KD; Alam KK; Lange MJ; Daniels MA; Burke DH
Nat Commun; 2018 Jun; 9(1):2283. PubMed ID: 29891903
[TBL] [Abstract][Full Text] [Related]
2. Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots.
Citartan M; Kaur H; Presela R; Tang TH
Int J Pharm; 2019 Aug; 567():118483. PubMed ID: 31260780
[TBL] [Abstract][Full Text] [Related]
3. The Three S's for Aptamer-Mediated Control of DNA Nanostructure Dynamics: Shape, Self-Complementarity, and Spatial Flexibility.
Shiu SC; Kinghorn AB; Sakai Y; Cheung YW; Heddle JG; Tanner JA
Chembiochem; 2018 Sep; 19(18):1900-1906. PubMed ID: 30007003
[TBL] [Abstract][Full Text] [Related]
4. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
5. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
Zhou J; Rossi JJ; Shum KT
Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
[TBL] [Abstract][Full Text] [Related]
6. DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells.
Wu Y; Sefah K; Liu H; Wang R; Tan W
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):5-10. PubMed ID: 20080797
[TBL] [Abstract][Full Text] [Related]
7. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
8. AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems.
Wang Y; Hoinka J; Liang Y; Adamus T; Swiderski P; Przytycka TM
Nucleic Acids Res; 2018 Sep; 46(16):8133-8142. PubMed ID: 29986050
[TBL] [Abstract][Full Text] [Related]
9. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.
Thiel KW; Hernandez LI; Dassie JP; Thiel WH; Liu X; Stockdale KR; Rothman AM; Hernandez FJ; McNamara JO; Giangrande PH
Nucleic Acids Res; 2012 Jul; 40(13):6319-37. PubMed ID: 22467215
[TBL] [Abstract][Full Text] [Related]
10. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific internalization study of an aptamer from whole cell selection.
Xiao Z; Shangguan D; Cao Z; Fang X; Tan W
Chemistry; 2008; 14(6):1769-75. PubMed ID: 18092308
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs.
Lee H; Dam DH; Ha JW; Yue J; Odom TW
ACS Nano; 2015 Oct; 9(10):9859-67. PubMed ID: 26335372
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Hybrid Aptamer-Fc Conjugates for Targeted Delivery: A Modular Chemoenzymatic Approach.
Dickgiesser S; Rasche N; Nasu D; Middel S; Hörner S; Avrutina O; Diederichsen U; Kolmar H
ACS Chem Biol; 2015 Sep; 10(9):2158-65. PubMed ID: 26131766
[TBL] [Abstract][Full Text] [Related]
14. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell targeting using multiple aptamers conjugated on nanorods.
Huang YF; Chang HT; Tan W
Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
[TBL] [Abstract][Full Text] [Related]
16. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
[TBL] [Abstract][Full Text] [Related]
17. Structural Principles of Fluorescent RNA Aptamers.
Trachman RJ; Truong L; Ferré-D'Amaré AR
Trends Pharmacol Sci; 2017 Oct; 38(10):928-939. PubMed ID: 28728963
[TBL] [Abstract][Full Text] [Related]
18. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
[TBL] [Abstract][Full Text] [Related]
19. Aptamers as Functional Modules for DNA Nanostructures.
Shiu SC; Kinghorn AB; Guo W; Slaughter LS; Ji D; Mo X; Wang L; Tran NC; Kwok CK; Shum AHC; Tse ECM; Tanner JA
Methods Mol Biol; 2023; 2639():301-337. PubMed ID: 37166724
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
